Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

JANUS FAMILY KINASES AND IDENTIFICATION OF IMMUNE MODULATORS (JAK-3)c

  • Read more about JANUS FAMILY KINASES AND IDENTIFICATION OF IMMUNE MODULATORS (JAK-3)c
US Patent 7,070,972
Filed on 1995-01-13

ANTI-HIV PROTEINS GAP 31, DAP 30 AND DAP 32, DNA CODING THEREFOR AND THERAPEUTIC USES THEREOF

  • Read more about ANTI-HIV PROTEINS GAP 31, DAP 30 AND DAP 32, DNA CODING THEREFOR AND THERAPEUTIC USES THEREOF
US Application 08/181,303
Filed on 1994-01-13

ANTIMALARIAL NAPHTHYLISOQUINOLINE ALKALOIDS AND PHARMACEUTICAL COMPOSITIONS AND MEDICAL USES THEREOF

  • Read more about ANTIMALARIAL NAPHTHYLISOQUINOLINE ALKALOIDS AND PHARMACEUTICAL COMPOSITIONS AND MEDICAL USES THEREOF
US Patent 5,639,761
Filed on 1994-02-14

TAXOL TREATMENT OF BREAST CANCER

  • Read more about TAXOL TREATMENT OF BREAST CANCER
US Patent 5,496,846
Filed on 1994-01-06

METHOD OF INHIBITING KAPOSI'S SARCOMA

  • Read more about METHOD OF INHIBITING KAPOSI'S SARCOMA
US Application 08/105,900
Filed on 1993-08-12

COMPOSITIONS AND METHODS FOR THERAPY AND PREVENTION OF PATHOLOGIES INCLUDING CANCER

  • Read more about COMPOSITIONS AND METHODS FOR THERAPY AND PREVENTION OF PATHOLOGIES INCLUDING CANCER
US Patent 5,605,930
Filed on 1994-03-07

RECOMBINANT VACCINNIA VIRUS ENCODING CYTOCHROMES P-450

  • Read more about RECOMBINANT VACCINNIA VIRUS ENCODING CYTOCHROMES P-450
US Patent 5,506,138
Filed on 1993-12-13

THE DESIGN AND CONSTRUCTION OF NON-INFECTIOUS HUMAN RETROVIRAL MUTANTS DEFICIENT IN GENOMIC RNA

  • Read more about THE DESIGN AND CONSTRUCTION OF NON-INFECTIOUS HUMAN RETROVIRAL MUTANTS DEFICIENT IN GENOMIC RNA
US Patent 5,674,720
Filed on 1994-01-03

METHOD FOR DESIGNING CANCER TREATMENT REGIMENS AND METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER

  • Read more about METHOD FOR DESIGNING CANCER TREATMENT REGIMENS AND METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER
US Application 08/169,962
Filed on 1993-12-20

PROTEIN-DENDRIMER-CHELATE-METAL COMPLEXES FOR RADIOIMMUNOTHERAPY AND DIAGNOSTIC IMAGING

  • Read more about PROTEIN-DENDRIMER-CHELATE-METAL COMPLEXES FOR RADIOIMMUNOTHERAPY AND DIAGNOSTIC IMAGING
US Application 08/194,444
Filed on 1994-02-10

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1591
  • Page 1592
  • Page 1593
  • Page 1594
  • Page 1595
  • Page 1596
  • Page 1597
  • Page 1598
  • Page 1599
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health